Skip to main navigation Skip to search Skip to main content

Development of pancreatic diseases during long-term follow-up after acute pancreatitis: a post-hoc analysis of a prospective multicenter cohort

*Corresponding author for this work
  • St. Antonius Ziekenhuis
  • Erasmus MC
  • St. Antonius Hospital
  • Erasmus University Rotterdam
  • Leiden University Medical Center
  • Leiden University
  • Radboud University Medical Center
  • Radboud University Nijmegen
  • Amsterdam UMC location University of Amsterdam
  • Amsterdam UMC
  • University of Amsterdam
  • St. Franciscus Hospital
  • Meander Medisch Centrum
  • Meander Medical Center
  • Catharina Hospital
  • Gelre Ziekenhuizen
  • Department of Medical Oncology, Elisabeth-Tweesteden Hospital, Tilburg, The Netherlands
  • Onze Lieve Vrouwe Gasthuis
  • OLVG West
  • Isala Clinics
  • Reinier de Graaf Groep
  • Jeroen Bosch Ziekenhuis
  • Rijnstate Hospital
  • Canisius Wilhelmina Hospital
  • University Medical Center Utrecht
  • Utrecht University
  • Diakonessenhuis Utrecht
  • Gelderland Valley Hospital
  • Ziekenhuis Gelderse Vallei
  • Columbia University
  • Columbia University Medical Center
  • Maastricht UMC+
  • Maastricht University
  • University of Limburg

Research output: Contribution to journal › Article › Academic › peer-review

53 Downloads (Pure)

Abstract

Background and Aim: More insight into the incidence of and factors associated with progression following a first episode of acute pancreatitis (AP) would offer opportunities for improvements in disease management and patient counseling. Methods: A long-term post hoc analysis of a prospective cohort of patients with AP (2008–2015) was performed. Primary endpoints were recurrent acute pancreatitis (RAP), chronic pancreatitis (CP), and pancreatic cancer. Cumulative incidence calculations and risk analyses were performed. Results: Overall, 1184 patients with a median follow-up of 9 years (IQR: 7–11) were included. RAP and CP occurred in 301 patients (25%) and 72 patients (6%), with the highest incidences observed for alcoholic pancreatitis (40% and 22%). Pancreatic cancer was diagnosed in 14 patients (1%). Predictive factors for RAP were alcoholic and idiopathic pancreatitis (OR 2.70, 95% CI 1.51–4.82 and OR 2.06, 95% CI 1.40–3.02), and no pancreatic interventions (OR 1.82, 95% CI 1.10–3.01). Non-biliary etiology (alcohol: OR 5.24, 95% CI 1.94–14.16, idiopathic: OR 4.57, 95% CI 2.05–10.16, and other: OR 2.97, 95% CI 1.11–7.94), RAP (OR 4.93, 95% CI 2.84–8.58), prior pancreatic interventions (OR 3.10, 95% CI 1.20–8.02), smoking (OR 2.33, 95% CI 1.14–4.78), and male sex (OR 2.06, 95% CI 1.05–4.05) were independently associated with CP. Conclusion: Disease progression was observed in a quarter of pancreatitis patients. We identified several risk factors that may be helpful to devise personalized strategies with the intention to reduce the impact of disease progression in patients with AP.
Original languageEnglish
Pages (from-to)674-684
Number of pages11
JournalJournal of gastroenterology and hepatology
Volume39
Issue number4
Early online date2024
DOIs
Publication statusPublished - Apr 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • acute pancreatitis
  • chronic pancreatitis
  • pancreatic cancer
  • progression

Fingerprint

Dive into the research topics of 'Development of pancreatic diseases during long-term follow-up after acute pancreatitis: a post-hoc analysis of a prospective multicenter cohort'. Together they form a unique fingerprint.

Cite this